L-Dopa and schizophrenia.
D001921:Brain / Q000378:metabolism; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008137:Longitudinal Studies; D008875:Middle Aged; D010919:Placebos; D012075:Remission, Spontaneous; D012560:Schizophrenia, Catatonic / Q000188:drug therapy*
D010919:Placebos; D007980:Levodopa; D002262:Carboxy-Lyases; D004298:Dopamine